Views of Wall Street’s Leading Experts on TransMedics Group Inc.

TransMedics Group Inc. (NASDAQ: TMDX) stock jumped 0.69% on Friday to $59.54 against a previous-day closing price of $59.13. With 0.88 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.66 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $59.66 whereas the lowest price it dropped to was $57.88. The 52-week range on TMDX shows that it touched its highest point at $99.63 and its lowest point at $38.86 during that stretch. It currently has a 1-year price target of $95.50. Beta for the stock currently stands at 1.53.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TMDX was up-trending over the past week, with a rise of 1.66%, but this was down by -6.16% over a month. Three-month performance dropped to -25.24% while six-month performance fell -21.76%. The stock gained 13.65% in the past year, while it has lost -3.53% so far this year. A look at the trailing 12-month EPS for TMDX yields -0.57 with Next year EPS estimates of -0.16. For the next quarter, that number is -0.16. This implies an EPS growth rate of 23.40% for this year and 63.60% for next year.

Float and Shares Shorts:

At present, 32.55 million TMDX shares are outstanding with a float of 31.46 million shares on hand for trading. On Aug 30, 2023, short shares totaled 4.15 million, which was 12.71% higher than short shares on Jul 30, 2023. In addition to Dr. Waleed H. Hassanein M.D. as the firm’s Founder, Pres, CEO & Director, Mr. Stephen Gordon serves as its CFO, Treasurer & Sec.

Institutional Ownership:

Other institutions hold 60.10% of TMDX, in contrast to 41.13% held by mutual funds. Shares owned by individuals account for 19.78%. As the largest shareholder in TMDX with 9.12% of the stake, Fidelity Management & Research Co holds 2,975,180 shares worth 2,975,180. A second-largest stockholder of TMDX, BlackRock Fund Advisors, holds 2,067,575 shares, controlling over 6.34% of the firm’s shares. Lord, Abbett & Co. LLC is the third largest shareholder in TMDX, holding 1,869,739 shares or 5.73% stake. With a 2.93% stake in TMDX, the Delaware Small Cap Core Fund is the largest stakeholder. A total of 955,098 shares are owned by the mutual fund manager. The Vanguard Total Stock Market ETF, which owns about 2.92% of TMDX stock, is the second-largest Mutual Fund holder. It holds 953,421 shares valued at 62.57 million. Fidelity Advisor Series I -Growth holds 2.71% of the stake in TMDX, owning 882,617 shares worth 57.93 million.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, TMDX reported revenue of $20.52M and operating income of -$9.74M. The EBITDA in the recently reported quarter was -$10.53M and diluted EPS was -$0.41.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TMDX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With TMDX analysts setting a high price target of $110.00 and a low target of $81.00, the average target price over the next 12 months is $96.20. Based on these targets, TMDX could surge 84.75% to reach the target high and rise by 36.04% to reach the target low. Reaching the average price target will result in a growth of 61.57% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded TMDX stock several times over the past three months with 4 Buys and 9 Sells. In these transactions, 17,486 shares were bought while 25,199 shares were sold. The number of buy transactions has increased to 65 while that of sell transactions has risen to 101 over the past year. The total number of shares bought during that period was 797,213 while 397,321 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *